Share-based Compensation (Tables)
|
3 Months Ended |
Mar. 31, 2021 |
|---|
| Share-based Compensation |
|
| Schedule of information about 2019 plan |
The following table contains information about the 2019 Plan as of March 31, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards
|
|
|
|
Awards Reserved for
|
|
|
|
Available for
|
|
|
|
Issuance
|
|
Awards Issued
|
|
Grant
|
|
2019 Plan
|
|
17,000,000
|
|
14,705,949
|
|
2,294,051
|
|
| Schedule of incentive stock option activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
Number of
|
|
Weighted Average
|
|
Contractual
|
|
|
|
Options
|
|
Exercise Price
|
|
Term in Years
|
|
Outstanding at January 1, 2020
|
|
1,000,000
|
|
$
|
0.053525
|
|
9.6
|
|
Granted
|
|
12,705,949
|
|
$
|
0.0291
|
|
10.0
|
|
Exercised
|
|
—
|
|
|
—
|
|
—
|
|
Forfeited
|
|
—
|
|
|
—
|
|
—
|
|
Cancelled
|
|
—
|
|
|
—
|
|
—
|
|
Expired
|
|
—
|
|
|
—
|
|
—
|
|
Outstanding at December 31, 2020
|
|
13,705,949
|
|
$
|
0.027736
|
|
9.32
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
1,666,667
|
|
$
|
0.08
|
|
10.0
|
|
Exercised
|
|
—
|
|
|
—
|
|
—
|
|
Forfeited
|
|
—
|
|
|
—
|
|
—
|
|
Cancelled
|
|
—
|
|
|
—
|
|
—
|
|
Expired
|
|
—
|
|
|
—
|
|
—
|
|
Outstanding at March 31, 2021
|
|
15,372,616
|
|
$
|
0.034889
|
|
9.16
|
|
Exercisable at March 31, 2021
|
|
9,105,949
|
|
$
|
0.025441
|
|
9.00
|
|
| Schedule of assumptions used in share-based compensation |
The following assumptions were used to calculate share-based compensation expense for three months ended March 31, 2021:
|
|
|
|
|
|
Volatility
|
|
171.12%- 172.19
|
%
|
|
Risk-free interest rate
|
|
0.46% - 0.86
|
%
|
|
Dividend yield
|
|
0.0
|
%
|
|
Expected term
|
|
5.0 – 5.25
|
years
|
|
| Schedule of restricted stock awards activity |
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Weighted Average
|
|
|
|
Units
|
|
Grant Date Fair Value
|
|
|
|
|
|
|
|
|
Granted
|
|
7,311,904
|
|
$
|
0.023
|
|
Exercised and converted to common shares
|
|
(5,928,571)
|
|
|
0.014
|
|
Forfeited
|
|
—
|
|
|
—
|
|
Outstanding at December 31, 2020
|
|
1,383,333
|
|
$
|
0.060
|
|
Granted
|
|
—
|
|
|
—
|
|
Exercised and converted to common shares
|
|
—
|
|
|
—
|
|
Forfeited
|
|
—
|
|
|
—
|
|
Outstanding at March 31, 2021
|
|
1,383,333
|
|
$
|
0.060
|
|
Exercisable at March 31,2021
|
|
691,666
|
|
$
|
0.060
|
|
| Summary of common stock warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
Weighted
|
|
|
|
|
|
Average
|
|
Average
|
|
|
|
Number of
|
|
Exercise
|
|
Contractual
|
|
|
|
Warrants
|
|
Price
|
|
Term in Years
|
|
Outstanding at December 31, 2019
|
|
5,250,000
|
|
$
|
0.014000
|
|
2.81
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
2,117,500
|
|
$
|
0.050720
|
|
5.00
|
|
Exercised
|
|
—
|
|
|
—
|
|
—
|
|
Forfeited
|
|
—
|
|
|
—
|
|
—
|
|
Cancelled
|
|
—
|
|
|
—
|
|
—
|
|
Expired
|
|
—
|
|
|
—
|
|
—
|
|
Outstanding at December 31, 2020
|
|
7,367,500
|
|
$
|
0.050720
|
|
2.54
|
|
Granted
|
|
12,460,000
|
|
$
|
0.135188
|
|
4.77
|
|
Exercised
|
|
—
|
|
|
—
|
|
—
|
|
Forfeited
|
|
—
|
|
|
—
|
|
—
|
|
Cancelled
|
|
—
|
|
|
—
|
|
—
|
|
Expired
|
|
—
|
|
|
—
|
|
—
|
|
Outstanding at March 31, 2021
|
|
19,827,500
|
|
$
|
0.094078
|
|
3.52
|
|
Exercisable at March 31, 2021
|
|
19,827,500
|
|
$
|
0.094078
|
|
3.52
|
|